CTI BIOPHARMA CORP Quarterly Common Stock, Shares, Outstanding from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cti Biopharma Corp quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2010 to Q1 2023.
  • Cti Biopharma Corp Common Stock, Shares, Outstanding for the quarter ending March 31, 2023 was 132M shares, a 31.1% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 132M +31.3M +31.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 131M +31M +31.1% Dec 31, 2022 10-Q 2023-05-15
Q3 2022 127M +30.2M +31.2% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 114M +20.8M +22.3% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 101M +23.9M +31.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 99.8M +23.9M +31.4% Dec 31, 2021 10-K 2023-03-06
Q3 2021 96.7M +23M +31.2% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 93.3M +19.6M +26.6% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 76.8M +3.07M +4.17% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 75.9M +17.9M +30.9% Dec 31, 2020 10-K 2022-03-31
Q3 2020 73.7M +15.7M +27.1% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 73.7M +15.7M +27.1% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 73.7M +15.7M +27.1% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 58M -6.35K -0.01% Dec 31, 2019 10-K 2021-03-17
Q3 2019 58M -9.98K -0.02% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 58M -6.2K -0.01% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 58M -1.58K 0% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 58M +15M +34.9% Dec 31, 2018 10-K 2020-03-13
Q3 2018 58M +15M +34.9% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 58M +15M +34.9% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 58M +29.8M +105% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 43M +14.7M +52.2% Dec 31, 2017 10-K 2019-03-13
Q3 2017 43M -240M -84.8% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 43M -240M -84.8% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 28.2M -252M -89.9% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 28.2M +182K +0.65% Dec 31, 2016 10-K 2018-03-07
Q3 2016 283M +90.7M +47.3% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 283M +102M +56.8% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 280M +100M +55.5% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 28M -149M -84.1% Dec 31, 2015 10-K 2017-03-02
Q3 2015 192M +41.7M +27.8% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 180M +30.4M +20.3% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 180M +30.4M +20.3% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 177M +31.3M +21.5% Dec 31, 2014 10-K 2016-02-17
Q3 2014 150M +20.3M +15.6% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 150M +35.2M +30.6% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 150M +37.2M +33% Mar 31, 2014 10-Q 2014-04-29
Q4 2013 146M +35.7M +32.5% Dec 31, 2013 10-K 2015-03-12
Q3 2013 130M +67.6M +109% Sep 30, 2013 10-Q 2013-10-30
Q2 2013 115M -146M -56.1% Jun 30, 2013 10-Q 2013-07-31
Q1 2013 113M -114M -50.3% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 110M +69.2M +170% Dec 31, 2012 10-K 2014-03-04
Q3 2012 62.3M -131M -67.7% Sep 30, 2012 10-Q 2012-11-01
Q2 2012 261M +86M +49.1% Jun 30, 2012 10-Q 2012-08-02
Q1 2012 227M Mar 31, 2012 10-Q 2012-04-20
Q4 2011 40.6M -95M -70.1% Dec 31, 2011 10-K 2013-02-28
Q3 2011 193M -566M -74.6% Sep 30, 2011 10-Q 2011-10-25
Q2 2011 175M -538M -75.4% Jun 30, 2011 10-Q 2011-07-28
Q4 2010 136M Dec 31, 2010 10-K 2012-03-08
Q3 2010 758M Sep 30, 2010 10-Q 2010-10-28
Q2 2010 714M Jun 30, 2010 10-Q 2010-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.